ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1809

Mass Spectrometry-Based N-Terminomics Uncovers Proteolytic Signatures and Pathways in Juvenile Idiopathic Arthritis Synovial Fluid

Andrew Zeft1, Sirada Panupattanapong2, Laura Nedorezov3, Sumit Bhutada3 and Suneel Apte3, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland, OH, 3Cleveland Clinic, Cleveland

Meeting: ACR Convergence 2025

Keywords: Biomarkers, Juvenile idiopathic arthritis, Pediatric rheumatology, proteomics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic disease marked by persistent synovial inflammation, often leading to structural joint damage. While numerous proteases produced by synovial cells, chondrocytes, macrophages, and polymorphonuclear cells were implicated in joint damage in rheumatoid arthritis, few studies explored similar mechanisms in JIA. Targeting proteolysis represents a promising disease-modifying strategy and may yield novel biomarkers for JIA, but this approach requires a comprehensive understanding of proteolytic activity. The study objective was to utilize N-terminomics to define the proteolytic landscape of JIA joints.

Methods: Synovial fluid samples (n=5) were collected from JIA patients under an approved IRB protocol. Proteins were labeled at their N-termini using reductive dimethylation. Samples underwent trypsin digestion, followed by enrichment of N-terminally labeled or modified peptides using HPG-ALD polymer. Peptides were further separated by high-pH off-line fractionation and analyzed on a Bruker TimsTOF Pro mass spectrometer. High-confidence peptides were identified using a stringent false discovery rate and mapped to full-length protein sequences to determine cleavage sites. Proteases present in the samples were also identified.

Results: This analysis of JIA synovial fluid identified 13,268 proteolytically cleaved peptides from 854 proteins. Of these, 5,805 peptides (44%) originated from secreted proteins, reflecting the prevalence of circulating proteins in synovial fluid. Notably, 2,732 peptides (19.2%) were detected in all five samples. Comparison with the previously characterized osteoarthritis (OA) synovial fluid degradome showed 6,978 cleavage sites (32.9%) from 325 proteins to be unique in JIA synovial fluid. Ingenuity Pathway Analysis of peptides unique to JIA identified neutrophil degranulation as the most significant pathway. In total, 95 proteases were detected in JIA synovial fluid, including neutrophil-derived proteases and others distinct from OA synovial fluid.

Conclusion: Our findings demonstrate a vast proteolytic landscape of JIA synovial fluid, providing an unprecedented expansion of proteolytic events and identifying potentially causative proteases. Implication of neutrophil activity in protein and joint breakdown highlights the relatively neglected role of innate immunity in JIA and identifies numerous potential biomarkers of their impact. Continued degradome analysis of larger JIA cohorts and stratification by clinical variables will be crucial for elucidating affected pathways and advancing both diagnostic and therapeutic strategies for JIA.


Disclosures: A. Zeft: GE Healthcare, 12,, Merck/MSD, 12,, Opko, 12,, Sobi, 1, Teva, 12,; S. Panupattanapong: None; L. Nedorezov: None; S. Bhutada: None; S. Apte: None.

To cite this abstract in AMA style:

Zeft A, Panupattanapong S, Nedorezov L, Bhutada S, Apte S. Mass Spectrometry-Based N-Terminomics Uncovers Proteolytic Signatures and Pathways in Juvenile Idiopathic Arthritis Synovial Fluid [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/mass-spectrometry-based-n-terminomics-uncovers-proteolytic-signatures-and-pathways-in-juvenile-idiopathic-arthritis-synovial-fluid/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mass-spectrometry-based-n-terminomics-uncovers-proteolytic-signatures-and-pathways-in-juvenile-idiopathic-arthritis-synovial-fluid/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology